Midodrine

What it is

A prescription-only oral drug (US, EU, UK where licensed) for symptomatic low blood pressure on standing. The body converts it to desglymidodrine, an alpha-1 adrenergic agonist that tightens blood vessels. It is generic. No topical product exists.

How it works

Each scalp follicle has a small smooth muscle, the arrector pili, that stands the hair up through alpha-1 receptors. Midodrine triggers it so reliably that its US label attributes goosebumps and scalp tingling to "the alpha-adrenergic receptors of the hair follicles".

A tightened muscle grips the hair more firmly. A small industry group showed that:

• Topical phenylephrine, a strong alpha-1 agonist, raised plucking force by about 172% and cut shedding during styling by about 42% in young women. Goren 2016
• A high concentration of a weak alpha-1 agonist cut hairs shed in brushing by 38% on average with no heart-rhythm changes. McCoy 2018
• A synephrine plus tyramine formula cut brushing shedding by 62.5% on the treated side in a split-scalp study of 76 women. Mehta 2025

These are acute anchoring effects on hairs that are already loose. They do not show more hair growing.

A second story concerns stem cells. In mice, sympathetic nerves and the arrector pili form a niche that keeps follicle stem cells active. Shwartz 2020 But older mouse work found that removing noradrenaline triggered early hair growth, Peters 1999 and a 2026 mouse paper found stress surges of noradrenaline can kill follicle cells and prime autoimmunity. Scott-Solomon 2026 So the effect depends on dose and context, and none of it is shown in people.

What the studies show

• No study of midodrine, oral or topical, on hair growth or shedding exists, and no hair trial is registered (checked 2026-10-10).
• In the label's placebo-controlled trial (170 people), goosebumps occurred in 13.4% vs 0% on placebo, scalp-including tingling in 18.3% vs 4.5%, and scalp-including itch in 12.2% vs 2.3%. US label
• In a 97-person RCT, scalp itch or tingling was the most common side effect at 13.5%. Jankovic 1993
• A meta-analysis confirmed raised risks of goosebumps, scalp itch and scalp tingling. Parsaik 2013
• In 18 scalp biopsies, the arrector pili muscle was replaced by fat in all balding (androgenetic) samples, so the muscle may be missing where people want it. Torkamani 2014

How it's used in studies

Oral 2.5-10 mg three times daily for low blood pressure in the 1993 RCT. The anti-shedding products were applied minutes before brushing or styling and used other alpha-1 agonists, not midodrine.

Side effects and safety

Oral midodrine carries a boxed warning for high blood pressure when lying down, and can cause urinary retention, slow heart rate, chills, goosebumps and scalp tingling. Any alpha-1 agonist absorbed through the scalp can raise blood pressure; the anti-shedding developers moved away from phenylephrine for this reason. Prescription-only.

Bottom line

Midodrine is a hair curiosity, not a hair treatment. The only benefit shown for the drug class is a temporary cut in shedding during brushing, from one company-linked group; for midodrine itself there is only mechanism. For real hair loss see minoxidil and finasteride. Discuss with a doctor.

Fun facts

• The tiny goosebump muscle can grip a hair hard enough that an alpha-1 agonist raised plucking force by about 172% in one small study. Goren 2016
• In balding scalp, the goosebump muscle is replaced by fat. Torkamani 2014